|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0092 - 0.0092|
|52 Week Range||0.0031 - 0.0400|
|Beta (5Y Monthly)||2.01|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Earth Life Sciences Inc., (the “Company”) (OTC "CLTS") is pleased to announce that it has reached an agreement with the Miltean Technology Group to provide an Artificial Intelligence (“AI”)-driven "mileage based" loyalty system for public transportation. The purpose of Miltean’s AI is to identify what loyalty rewards and incentives should be given to whom and when to entice maximum-efficiency usage of public transportation based on unique rider behaviour. The term "maximum efficiency" is a strategy such as return on investment (ROI); increase of ridership, decongestion analysis, interruption of service compensation, congestion management, prediction and analysis of ridership usage patterns.
Earth Life Sciences Inc., (the “Company”) (OTC "CLTS") announces recent progress in the activities of the Company. The Company has completed draft financial statements, with the next step being the review and/or audit of these documents and records by the Company’s auditors. The Company is desirous of regaining its OTC Markets QB status, by completing the necessary filings.